secwatch.observer — SEC 8-K summary
======================================

Issuer:     GERON CORP (GERN)
CIK:        0000886744
Form:       8-K
Filed at:   2022-06-15T23:59:59+00:00
Accession:  0001206774-22-001546
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Geron CMO Aleksandra Rizo resigns; Faye Feller named new CMO
------------------------------------------------------------

- Dr. Aleksandra Rizo resigns as EVP and CMO, effective July 8, 2022, to join a private discovery-stage biotech.
- Rizo will remain as Senior Medical and Regulatory Advisor, assisting with IMerge Phase 3 trial data and potential NDA.
- Dr. Faye Feller promoted to EVP and CMO effective July 9; she joined Geron in 2019 from Janssen.
- Feller previously served as Study Responsible Physician for imetelstat's IMbark Phase 2 trial at Janssen.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/886744/000120677422001546/0001206774-22-001546-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/886744/000120677422001546/geron4073661-8k.htm
  HTML page:      https://secwatch.observer/filing/0001206774-22-001546

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer